Clinical and Genetic Analysis of ROP

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

July 1, 2011

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2030

Conditions
Retinopathy of Prematurity
Interventions
OTHER

No intervention administered.

Eye exams are standard of care and would be performed regardless of participation in this study.

Trial Locations (5)

48073

RECRUITING

William Beaumont Hospital, Royal Oak

60607

RECRUITING

University of Illinois Chicago, Chicago

84132

NOT_YET_RECRUITING

University of Utah, Salt Lake City

94303

NOT_YET_RECRUITING

Stanford University, Palo Alto

97239

RECRUITING

Oregon Health & Science University, Portland

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

U.S. National Science Foundation

FED

collaborator

Massachusetts General Hospital

OTHER

collaborator

Northeastern University

OTHER

collaborator

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

OTHER

collaborator

William Beaumont Hospitals

OTHER

collaborator

University of Illinois at Chicago

OTHER

collaborator

Stanford University

OTHER

collaborator

University of Utah

OTHER

collaborator

National Eye Institute (NEI)

NIH

lead

Oregon Health and Science University

OTHER

NCT04420156 - Clinical and Genetic Analysis of ROP | Biotech Hunter | Biotech Hunter